News & Events

27 June 2023

Sharon Bulger says play therapy has helped her son Zach communicate difficult feelings and learn to cope.

18 April 2023

Thirteen-year-old Jules Aouizerate has been playing hockey for most of his life. Aouizerate, who was diagnosed with leukemia four years ago, lives in France but always dreamed of coming to Canada because of his love for the sport. That dream came true this week thanks to Team Canada’s Men’s Masters Hockey team. The teen made the journey to Montreal to train with the pros and meet his hockey heroes.

30 March 2023

From neurological problems to hearing loss and infertility, survivors of medulloblastoma, an aggressive form of brain cancer, are left with severe physical and cognitive impairments and have an overall mortality rate 21 times higher than the general population. These findings are from a new study led by Dr. Hallie Coltin, a pediatric hematologist/oncologist and researcher at CHU Sainte-Justine and assistant clinical professor at Université de Montréal’s Faculty of Medicine.

31 January 2023

ertain brain cells may be inherently vulnerable to the kinds of mutations that cause fatal brain tumours in children and young adults, says a study whose international research team was co-led by a principal investigator at the Lady Davis Institute (LDI). The findings, recently published in the journal Nature Genetics, represent a significant advance in understanding the development of tumours known as high-grade gliomas. This could be significant in the design of clinical trials for new types of therapy.

16 January 2023

A Montreal research team, headed by the eminent Janusz Rak, Ph.D., continues to lead the way to the ‘next frontier’ in pediatric cancer screening, diagnosis, and treatment thanks to the support of visionary partners of The Children’s Foundation.

3 November 2022

The Initiative will accelerate the development of platforms, tools and treatments to support advancements across all areas of pediatric cancer care: prevention, diagnosis and treatment.

20 October 2022

Nanopores and precision medicine: A quasi-instantaneous diagnosis to accelerate leukemia patient management

4 April 2022

We did not observe a statistically significant change in the ASIRs of childhood cancer during the first 9 months of the COVID-19 pandemic in Canada compared with the period before the pandemic. Moreover, enrolment in clinical trials remained stable, and we did not observe an increase in the proportion of patients with metastatic disease or early mortality. Although these results are reassuring, continued surveillance is necessary to ascertain potential long-term negative effects of the COVID-19 pandemic among children with cancer.

9 March 2022

Brain cancer is the most common type of solid cancer in children, and can be notoriously difficult to target with interventions such as chemotherapy, radiation, or surgery. But the work of Brain Canada-funded researchers is shedding new light into our ability to treat this pernicious childhood illness.